Q2 2017

Filed Aug 14, 2017 · 10-Q · 45 days after period end · 0001654954-17-007584

Q2 2017 · 10-Q

Revenue

$0.00

— vs Q2 2016

Net Income

-$506.30K

N/M vs Q2 2016

EPS Diluted

-$0.02

N/M vs Q2 2016

Operating Income-$506,297N/M

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$0.00	$0.00	$0.00	$213.00
Net Income	-$506.30K	-$260.87K	-$112.63K	-$7.67K
EPS Diluted	-$0.02	-$0.03	-$0.22	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR